<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?open_access?><front><?epub 14-July-2005?><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">Nucleic Acids Research</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/nar/gki707</article-id><article-id pub-id-type="pmid">16027113</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Exonization of <italic>Alu</italic>Ya5 in the human <italic>ACE</italic> gene requires mutations in both 3&#x02032; and 5&#x02032; splice sites and is facilitated by a conserved splicing enhancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lei</surname><given-names>Haixin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Day</surname><given-names>Ian N. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vo&#x00159;echovsk&#x000fd;</surname><given-names>Igor</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff><institution>University of Southampton School of Medicine, Division of Human Genetics</institution><addr-line>Duthie Building, Mailpoint 808, Southampton SO16 6YD, UK</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><sup>*</sup>To whom correspondence should be addressed. Tel: +44 2380 796425, Fax: +44 2380 794264; Email: <email>igvo@soton.ac.uk</email></corresp></author-notes><!--For NAR: both ppub and collection dates generated for PMC processing 1/27/05 beck--><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="ppub"><year>2005</year></pub-date><pub-date pub-type="epub"><day>14</day><month>7</month><year>2005</year></pub-date><volume>33</volume><issue>12</issue><fpage>3897</fpage><lpage>3906</lpage><history><date date-type="received"><day>31</day><month>3</month><year>2005</year></date><date date-type="rev-recd"><day>13</day><month>6</month><year>2005</year></date><date date-type="accepted"><day>27</day><month>6</month><year>2005</year></date></history><copyright-statement>&#x000a9; The Author 2005. Published by Oxford University Press. All rights reserved</copyright-statement><copyright-year>2005</copyright-year><license license-type="openaccess"><p>The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact <email>journals.permissions@oupjournals.org</email></p></license><abstract><p>Ancient <italic>Alu</italic> elements have been shown to be included in mature transcripts by point mutations that improve their 5&#x02032; or 3&#x02032; splice sites. We have examined requirements for exonization of a younger, disease-associated <italic>Alu</italic>Ya5 in intron 16 of the human <italic>ACE</italic> gene. A single G&#x0003e;C transversion in position &#x02212;3 of the new <italic>Alu</italic> exon was insufficient for <italic>Alu</italic> exonization and a significant inclusion in mRNA was only observed when improving several potential splice donor sites in the presence of 3&#x02032; CAG. Since complete <italic>Alu</italic> exonization was not achieved by optimizing traditional splicing signals, including the branch site, we tested whether auxiliary elements in <italic>Alu</italic>Ya5 were required for constitutive inclusion. Exonization was promoted by a SELEX-predicted heptamer in <italic>Alu</italic> consensus sequence 222&#x02013;228 and point mutations in highly conserved nucleotides of this heptamer decreased <italic>Alu</italic> inclusion. In addition, we show that <italic>Alu</italic> exonization was facilitated by a subset of serine/arginine-rich (SR) proteins through activation of the optimized 3&#x02032; splice site. Finally, the haplotype- and allele-specific <italic>ACE</italic> minigenes generated similar splicing patterns in both ACE-expressing and non-expressing cells, suggesting that previously reported allelic association with plasma ACE activity and cardiovascular disease is not attributable to differential splicing of introns 16 and 17.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>Splicing removes introns from eukaryotic precursor (pre-)mRNA and joins exons together to form mature transcripts. This step-wise process involves multiple and relatively weak interactions of the pre-mRNA substrate, several small nuclear ribonucleoprotein particles (snRNPs U1, U2, U4/U6 and U5) and a large number of non-snRNP proteins (<xref ref-type="bibr" rid="b1">1</xref>&#x02013;<xref ref-type="bibr" rid="b3">3</xref>). In addition to numerous <italic>trans</italic>-acting factors, splicing requires <italic>cis</italic>-elements in the pre-mRNA that include the 5&#x02032; splice site (5&#x02032;ss; consensus MAG/GURAGU), branchpoint sequence (BPS; YNCURAY), polypyrimidine tract (PPT) and the 3&#x02032; splice site (3&#x02032;ss; YAG). These sequences are degenerate in higher eukaryotes, but are by no means sufficient for accurate splicing. Efficient intron removal often requires auxiliary sequences, known as exonic and intronic splicing enhancers (ESEs and ISEs) and silencers (ESSs and ISSs), that promote or inhibit splicing, respectively. Splicing enhancers have been identified through mutations or polymorphisms that alter splicing (<xref ref-type="bibr" rid="b4">4</xref>&#x02013;<xref ref-type="bibr" rid="b6">6</xref>), through computational comparisons (<xref ref-type="bibr" rid="b7">7</xref>&#x02013;<xref ref-type="bibr" rid="b9">9</xref>) and through selection of sequences that activate splicing or bind splicing regulatory factors (<xref ref-type="bibr" rid="b10">10</xref>,<xref ref-type="bibr" rid="b11">11</xref>), most notably a family of serine/arginine-rich (SR) proteins [reviewed in (<xref ref-type="bibr" rid="b12">12</xref>)]. Typically, SR proteins bind to ESEs in both constitutive and alternative exons through one or more N-terminal RNA recognition motifs (RRMs) (<xref ref-type="bibr" rid="b12">12</xref>). Unlike more extensively studied ESEs or ESSs, intronic auxiliary splicing signals have been studied in much less detail (<xref ref-type="bibr" rid="b13">13</xref>&#x02013;<xref ref-type="bibr" rid="b19">19</xref>).</p><p>Human introns contain a large number of repetitive elements that may influence pre-mRNA splicing (<xref ref-type="bibr" rid="b20">20</xref>&#x02013;<xref ref-type="bibr" rid="b27">27</xref>). The most abundant class of intronic repeats is represented by short interspersed elements that include <italic>Alu</italic> sequences. <italic>Alu</italic>s are primate-specific, &#x0223c;300 nt repeats that constitute &#x0223c;10% of the human genome in over 10<sup>6</sup> copies. <italic>Alu</italic> insertions may cause genetic disease (<xref ref-type="bibr" rid="b28">28</xref>&#x02013;<xref ref-type="bibr" rid="b30">30</xref>) and can contribute to protein diversity through exonization (<xref ref-type="bibr" rid="b31">31</xref>&#x02013;<xref ref-type="bibr" rid="b34">34</xref>). About 5% of alternatively spliced internal exons in the human genome contain an <italic>Alu</italic> sequence and <italic>Alu</italic>s have recently been shown to be exonized by single point mutations that improve their 5&#x02032; or 3&#x02032;ss (<xref ref-type="bibr" rid="b32">32</xref>,<xref ref-type="bibr" rid="b33">33</xref>). <italic>Alu</italic>s may therefore provide suitable systems for studying evolutionary aspects of both traditional and auxiliary splicing signals.</p><p>The human <italic>ACE</italic> gene encodes angiotensin converting enzyme (ACE; EC 3.4.15.1), which converts inactive angiotensin I into a critical vasoconstrictor and blood pressure regulator angiotensin II. Mice lacking ACE have low blood pressure, renal pathology and reduced male fertility (<xref ref-type="bibr" rid="b35">35</xref>,<xref ref-type="bibr" rid="b36">36</xref>). <italic>ACE</italic> has been identified as a major component of the genetic variance of highly heritable ACE plasma concentrations (<xref ref-type="bibr" rid="b37">37</xref>&#x02013;<xref ref-type="bibr" rid="b41">41</xref>). Closely linked <italic>ACE</italic> polymorphisms have been associated with cardiovascular diseases, including arterial hypertension, myocardial infarction, left ventricular hypertrophy and coronary arteriosclerosis (<xref ref-type="bibr" rid="b42">42</xref>&#x02013;<xref ref-type="bibr" rid="b47">47</xref>), and with Alzheimer's disease (<xref ref-type="bibr" rid="b48">48</xref>). In particular, associations of an insertion/deletion polymorphism (I/D) of antisense <italic>Alu</italic>Ya5 in <italic>ACE</italic> intron 16 with these phenotypes have been reported in a large number of independent studies, with meta-analyses supporting an association of a modest effect (<xref ref-type="bibr" rid="b47">47</xref>&#x02013;<xref ref-type="bibr" rid="b51">51</xref>). Detailed linkage disequilibrium studies have attempted to map ACE levels as a quantitative trait locus to a particular polymorphism within <italic>ACE</italic>, supporting I/D and several intragenic single nucleotide polymorphisms (SNPs) as probable candidates for causal variants (<xref ref-type="bibr" rid="b47">47</xref>,<xref ref-type="bibr" rid="b52">52</xref>,<xref ref-type="bibr" rid="b53">53</xref>). However, genetic mapping of low penetrance genes in regions with high linkage disequilibrium has major limitations in complex traits and a biological mechanism for the proposed allelic and haplotype association needs to be demonstrated. Although several hypotheses have been considered, including a putative influence of I/D haplotypes on transcriptional regulation (<xref ref-type="bibr" rid="b54">54</xref>), no reliable evidence has been provided to date.</p><p>Here, we have tested if <italic>ACE</italic> I/D and closely linked SNPs influence pre-mRNA splicing and expression of <italic>ACE</italic> transcripts using minigene assays. In addition, we have examined the requirements for I/D <italic>Alu</italic> exonization by modifying both traditional and auxiliary splicing signals. We found that this <italic>Alu</italic> could not be included in mature transcripts by improving either 3&#x02032; or 5&#x02032;ss and that the <italic>Alu</italic>Ya5 exonization required at least one mutation in both splice sites. This process was facilitated by a conserved ESE in the new <italic>Alu</italic> exon. Finally, we show that the <italic>Alu</italic> I/D inclusion in mRNA was promoted by a subset of SR proteins through increased utilization of the optimized 3&#x02032;ss.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Plasmid constructs</title><p>Minigenes A and B (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) were cloned into HindIII/EcoRI of pCR3.1 (Invitrogen) using primers 1 (5&#x02032;-gat caa gct taa gtg caa agg agt aca gct cat tg) and 2 (gat cga att cct cac tca cac tgt ggt ccg tct tt) and a DNA sample heterozygous for the I/D polymorphism. Constructs C&#x02013;F were made using minigenes A and B as templates and a combination of vector primers PL1 (act cac tat agg gag acc) and PL2 (ggc tga tca gcg ggt tta) with <italic>ACE</italic>-specific primers 3 (ctg gat ccgccc agc tcc cac att aga acaat), 4 (tcg gat cca agg gca ttt cct ggg cac gct gac) and 5 (ctg gat cct ccc atc ctt tct ccc att tct ct, <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Mutagenesis was carried out using a two-step overlap-extension PCR as described (<xref ref-type="bibr" rid="b6">6</xref>). ASF/SF2 cDNA that lacked the sequence cgg cgg ggg tgg agg tgg cgg encoding a heptaglycine motif between RRM1 and RRM2 was cloned as described (<xref ref-type="bibr" rid="b55">55</xref>). All constructs were validated by sequencing using automated sequencer ABI377 as described previously (<xref ref-type="bibr" rid="b56">56</xref>).</p></sec><sec><title>Cell lines and transient transfection</title><p>HeLa cells (derived from human cervix epitheloid carcinoma), PANC1 cells (human pancreatic ductal carcinoma) and human embryonic kidney 293T cells were transfected in 6-well or 12-well plates as described (<xref ref-type="bibr" rid="b6">6</xref>). Transient transfection was with FuGENE 6 (Roche) according to the manufacturer's recommendations. Cells were harvested for RNA extraction 48 h later. The genotype of ACE-expressing 293T and PANC1 cells was I/D, whereas non-expressing HeLa cells had genotype D/D.</p></sec><sec><title>Detection of <italic>ACE</italic> isoforms</title><p>Total RNA was extracted using Tri Reagent (Sigma, USA) according to the manufacturer's recommendation. RNA was resuspended in DEPC-treated water and quantified on a spectrophotometer. Two micrograms of RNA from each sample were treated with DNase I (Ambion, USA) and reverse-transcribed using M-MLV (Promega, USA) in the presence of RNasin (Promega) at 42&#x000b0;C for 1 h. RT&#x02013;PCR was carried out with vector-specific primers PL1/PL2 and a combination of vector primer PL1 and primer 6 (ggc agc ctg gtt gat gag tt) in exon 17 to validate the ratios of RNA products in independent amplifications (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The number of PCR cycles was 28 or lower to maintain approximately linear relationship between the RNA input and signal. RT&#x02013;PCR products were separated on agarose or polyacrylamide gels and the identity of each isoform was confirmed by sequencing as described (<xref ref-type="bibr" rid="b56">56</xref>). The relative ratios of RNA products were measured with FluorImager 595 using FluorQuant and Phoretix software (Nonlinear Dynamics Inc., USA).</p></sec></sec><sec><title>RESULTS</title><sec><title>A lack of haplotype-specific splicing pattern of <italic>ACE</italic> minigenes</title><p>To test the influence of <italic>ACE</italic> variants and <italic>Alu</italic> sequences on pre-mRNA splicing, we prepared minigene constructs carrying predisposing and protective haplotypes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) that have been identified previously in independent human populations (<xref ref-type="bibr" rid="b57">57</xref>,<xref ref-type="bibr" rid="b58">58</xref>). The constructs contained either full (minigene A, B) or truncated (C, D) intron 16. Since extensive self-complementarity in intronic sequences may influence exon inclusion through modifying secondary RNA structure (<xref ref-type="bibr" rid="b20">20</xref>) and intron 16 <italic>Alu</italic>s in the opposite orientation would be predicted to create stable stem&#x02013;loop structures (data not shown), we also deleted tandemly arranged sense <italic>Alu</italic> elements in the latter constructs to create minigenes E and F (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><p>Examination of the splicing pattern after transfection of the wild-type minigenes with (A, C, E) and without (B, D, F) <italic>Alu</italic>Ya5 into 293T (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), HeLa and PANC1 cells (data not shown) revealed a correctly spliced RNA product and a transcript retaining short intron 17, but no exon 17 skipping. Mutations in three SNPs located close to the 3&#x02032;ss of intron 16 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), including IVS16-11C/A in PPT that may weaken 3&#x02032;ss recognition, did not induce exon 17 skipping or intron 16 retention (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p></sec><sec><title><italic>ACE</italic> intron 16 I/D <italic>Alu</italic> is not exonized by a single mutation at the predicted splice acceptor site</title><p><italic>ACE</italic> intron 16 I/D <italic>Alu</italic> belongs to a young, rapidly accumulating Ya5 subfamily (<xref ref-type="bibr" rid="b59">59</xref>&#x02013;<xref ref-type="bibr" rid="b61">61</xref>), which tend to occupy less <italic>Alu</italic>-dense environment than older relatives of the Y subfamily or more ancient <italic>Alu</italic>S/J subfamilies (<xref ref-type="bibr" rid="b62">62</xref>). Exonization of old and intermediate <italic>Alu</italic>s could be achieved with a single mutation (<xref ref-type="bibr" rid="b33">33</xref>,<xref ref-type="bibr" rid="b34">34</xref>) and was facilitated by altering concentration of a protein involved in the 3&#x02032;ss selection (<xref ref-type="bibr" rid="b33">33</xref>) or U1 snRNA (<xref ref-type="bibr" rid="b34">34</xref>). We therefore examined requirements of a polymorphic, recently integrated and disease-associated <italic>Alu</italic> for constitutive inclusion in <italic>ACE</italic> mRNA.</p><p><xref ref-type="table" rid="tbl1">Table 1</xref> shows alignments of the consensus sequences of <italic>Alu</italic>J/S subfamilies with <italic>ACE Alu</italic>Ya5 at the predicted 3&#x02032;ss. Unlike the <italic>Alu</italic>J subfamily, most <italic>Alu</italic>S-derived exons have been spliced via proximal AG as they contain inactivating guanosine in the distal AG (position +3 relative to the proximal AG or &#x02212;2 relative to the distal AG, <xref ref-type="table" rid="tbl1">Table 1</xref>) (<xref ref-type="bibr" rid="b33">33</xref>). The proximal 3&#x02032; AG is repressed in the presence of guanosine &#x02212;3 (<xref ref-type="bibr" rid="b33">33</xref>). Comparison of <italic>ACE Alu</italic>Ya5 with exonized <italic>Alu</italic>s showed that this element was most similar to the <italic>Alu</italic>S subfamily (<xref ref-type="table" rid="tbl1">Table 1</xref>), suggesting that optimizing position &#x02212;3 relative to the proximal AG may exonize this sequence. We replaced guanosine &#x02212;3 with cytosine, which is a preferred nucleotide in competing AG sites (<xref ref-type="bibr" rid="b63">63</xref>,<xref ref-type="bibr" rid="b64">64</xref>) and the most evolutionarily conserved nucleotide in vertebrates (<xref ref-type="bibr" rid="b65">65</xref>), and examined the expression of <italic>Alu</italic>-containing isoforms after transfection (<xref ref-type="fig" rid="fig1">Figures 1A</xref> and <xref ref-type="fig" rid="fig2">2A</xref>). However, neither mRNA products transcribed from minigene A (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, data not shown) nor mRNA products transcribed from truncated minigene E (lanes 1&#x02013;2, <xref ref-type="fig" rid="fig2">Figure 2A</xref>) had any detectable exonization of <italic>ACE Alu</italic>Ya5.</p></sec><sec><title>Exonization of <italic>ACE Alu</italic>Ya5 by optimizing several 5&#x02032; splice sites in the presence of 3&#x02032;CAG</title><p>To test whether optimized 5&#x02032;ss can exonize this <italic>Alu</italic> in the presence of 3&#x02032; CAG or GAG, we mutated positions +2, +3 and +5 of the predicted 5&#x02032;ss (<xref ref-type="bibr" rid="b34">34</xref>). In addition, we improved the match to the 5&#x02032;ss consensus by introducing single nucleotide mutations in one upstream (position &#x02212;12 relative to the predicted 5&#x02032;ss) and two downstream (+136 and +220) potential splice donor sites (<xref ref-type="table" rid="tbl2">Table 2</xref>). Furthermore, we created a high Shapiro&#x02013;Senapathy score 5&#x02032;ss in position &#x02212;16 by multiple mutations in both the full-length (A) and truncated (E) constructs. To further improve recognition of the 3&#x02032;ss, we mutated the closest match (CAGUCA<sub>&#x02212;19</sub>C) to the BPS consensus to the almost invariant BPS of <italic>Saccharomyces cerevisiae</italic> (UACUAA<sub>&#x02212;19</sub>C), which is also an optimal mammalian BPS (<xref ref-type="bibr" rid="b66">66</xref>). <italic>Alu</italic>-containing isoforms (designated Alu-E for exonized Alu, <xref ref-type="fig" rid="fig1">Figure 1A</xref>) were quantified after transfection of mutated constructs into 293T cells. Although mutations at the 5&#x02032;ss in the presence of 3&#x02032; GAG did not exonize <italic>Alu</italic> (data not shown), combination of a strong 5&#x02032;ss at position &#x02212;16 with the 3&#x02032; CAG was capable of significant <italic>Alu</italic> inclusion. The <italic>Alu</italic> inclusion was further improved in reporters with the optimized BPS (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, lanes 3&#x02013;4, <xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). A point mutation of the putative BP [CAGUC(A<sub>&#x02212;19</sub>&#x0003e;U)C], which is located in the optimal distance from the 3&#x02032; AG (<xref ref-type="bibr" rid="b67">67</xref>), eliminated <italic>Alu</italic> from the mRNA (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, lane 5), suggesting that A<sub>&#x02212;19</sub> is the BP of the new <italic>Alu</italic> exon. Introduction of uridine at position +2 of the predicted 5&#x02032;ss, which creates a highly conserved GU consensus, was insufficient for <italic>Alu</italic> inclusion (lane 6), but when combined with the 3&#x02032; CAG, we observed &#x0223c;11% exonization (lane 7 and <xref ref-type="fig" rid="fig2">Figure 2D</xref>). In contrast to position +2U, mutations designed to improve putative base-pairing interactions with U1 snRNA (+3, +5) did not produce any <italic>Alu</italic> inclusion in the absence of the 5&#x02032; GU (lanes 8&#x02013;9 and 12), but further improved exonization when combined with +2U, with adenosine +3 being more efficient than guanosine +5 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, lanes 10&#x02013;11 and <xref ref-type="fig" rid="fig2">Figure 2D</xref>). Triple mutations at the predicted 5&#x02032;ss producing a good match to the 5&#x02032; consensus sequence resulted in <italic>Alu</italic> inclusion levels comparable to those produced by optimal BPS in constructs with 5&#x02032;ss in position &#x02212;16 (cf. lanes 13 and 4 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>). A C&#x0003e;G transversion in position &#x02212;12 (<xref ref-type="table" rid="tbl2">Table 2</xref>) led to activation of the 5&#x02032;ss in position &#x02212;16 (lane 14), presumably through improved match in position +5 of the 5&#x02032;ss. Sequencing of the RNA product generated by the +136C&#x0003e;T mutation showed that &#x0223c;30% of mature transcripts contained a longer, 256 nt <italic>Alu</italic> exon (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Finally, a construct mutated in position +220 (<xref ref-type="table" rid="tbl2">Table 2</xref>) did not produce any <italic>Alu</italic> inclusion despite a high-score 5&#x02032;ss consensus (data not shown), most probably due to a shortened distance between this and downstream 3&#x02032;ss and/or poor exon definition of a predicted 341 nt exon, which is more than twice the size of an average human exon.</p><p>Correlation of the Shapiro and Senapathy scores with <italic>Alu</italic> inclusion levels produced by minigenes mutated in the predicted 5&#x02032;ss was significant (<italic>r</italic> = 0.73, <italic>p</italic> = 0.02, <xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="table" rid="tbl2">Table 2</xref>). However, a slightly lower <italic>Alu</italic> inclusion observed for a clone with a high-score 5&#x02032;ss at position &#x02212;16 than for an optimized predicted 5&#x02032;ss (cf. lanes 3 and 13, <xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="table" rid="tbl2">Table 2</xref>) was indicative of the presence of auxiliary splicing signals outside a 9 nt 5&#x02032;ss consensus. Thus, despite limitations of the Shapiro&#x02013;Senapathy scores, such as independence of each position, they provided a reasonably good indicator of splicing outcomes, consistent with their high predictive values for utilization of competing alternative, mutated and cryptic donor sites (<xref ref-type="bibr" rid="b68">68</xref>,<xref ref-type="bibr" rid="b69">69</xref>).</p></sec><sec><title>Identification of splicing regulatory sequences in exonized <italic>ACE Alu</italic>Ya5</title><p>Strong traditional splicing signals did not result in complete exonization of the new <italic>Alu</italic> exon (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, lane 4), suggesting that a constitutive inclusion requires auxiliary elements in the new <italic>Alu</italic> exon or in flanking introns. We first used ESE prediction tools that may facilitate identification of putative ESEs in the exonized <italic>Alu</italic> sequence (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), including RESCUE-ESE (<xref ref-type="bibr" rid="b7">7</xref>), octamer ESE/ESS (<xref ref-type="bibr" rid="b9">9</xref>) and functional systematic evolution of ligands by exponential enrichment (SELEX) implemented in the ESE Finder facility (<xref ref-type="bibr" rid="b8">8</xref>). Putative ESEs (shown as segments 1&#x02013;6, <xref ref-type="fig" rid="fig3">Figure 3A</xref>) that did not overlap splice sites were individually deleted in minigene E that was optimized at the 3&#x02032; and 5&#x02032;ss (designated E&#x02032;, <xref ref-type="fig" rid="fig3">Figure 3A</xref>). Deletion of segment 2 substantially reduced exonization (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, lane 2), whereas deletions of segments 3&#x02013;5 failed to do so (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, lanes 3&#x02013;5). Mutagenesis of each position in this heptamer to reduce <italic>Alu</italic> inclusion showed that a T&#x0003e;G transversion in position 5 had the strongest effect (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, lanes 6&#x02013;14). This alteration had one of the lowest SRp40 matrix scores (<xref ref-type="bibr" rid="b8">8</xref>), although no overall correlation was found between matrix scores and <italic>Alu</italic> inclusion levels (<italic>P</italic> &#x0003e; 0.2, <xref ref-type="fig" rid="fig3">Figure 3B</xref>). Mutation of the last heptamer position, which increased the SRp40 matrix score, did not alter exonization (data not shown). To test whether double mutations with minimized matrix scores can further reduce <italic>Alu</italic> inclusion, we created constructs containing either mutations 3G/4T (matrix score 0.24) or mutations 1G/5G (matrix score 0.42) in segment 2 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Mutations 3G/4T had no effect, whereas mutations 1G/5G reduced <italic>Alu</italic> exonization to a level observed for the segment 2 deletion. Finally, since segments bridging the splice sites could not be deleted, two mutations were introduced at positions 1 and 3 of segment 6 (<underline>C</underline>C<underline>A</underline>CAGg to <underline>G</underline>C<underline>G</underline>CAGg, <xref ref-type="fig" rid="fig3">Figure 3A</xref>). <italic>Alu</italic> exonization was reduced to 31% (lane 15, <xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><p>Comparison of segment 2 sequence with exonized <italic>Alu</italic>s (<xref ref-type="bibr" rid="b34">34</xref>) showed that this heptamer was invariant (<italic>n</italic> = 18) or had only a single nucleotide change (<italic>n</italic> = 12) in 35 exons that contained the right arms of exonized <italic>Alu</italic>s in antisense orientation. The last heptamer position was least conserved. In contrast, positions 1 and 5, which were most efficient in reducing <italic>Alu</italic> exonization (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), were virtually invariant (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), suggesting that they are critical for the splicing enhancement observed for segment 2. Variability of the heptamer was greater in <italic>Alu</italic> exons derived from Jb subfamilies (13 changes in 12 exons) than those derived from S subfamilies (11 changes in 19 exons). In addition, the heptamer sequence was invariant in most of over 8000 <italic>Alu</italic>s that were identified as amenable to exonization [(<xref ref-type="bibr" rid="b34">34</xref>), data not shown]. Alignment of consensus sequences of major <italic>Alu</italic> subfamilies (<xref ref-type="bibr" rid="b62">62</xref>,<xref ref-type="bibr" rid="b70">70</xref>) with <italic>ACE Alu</italic>Ya5 also showed a high degree of conservation of segment 2 in all <italic>Alu</italic> subfamilies, except for <italic>Alu</italic>Sp. This subfamily typically contains cytosine in position 5, which decreased the SRp40 matrix score, but not <italic>Alu</italic> inclusion (lane 12, <xref ref-type="fig" rid="fig3">Figure 3B</xref>). Interestingly, among 61 <italic>Alu</italic>-derived exons (<xref ref-type="bibr" rid="b34">34</xref>), we found only a single <italic>Alu</italic>Sp entry.</p></sec><sec><title>SR-mediated inclusion of <italic>ACE</italic> I/D <italic>Alu</italic> in mature transcripts</title><p>To test whether <italic>Alu</italic> exonization is influenced by factors known to control RNA processing, we co-transfected the wild-type reporters (data not shown) and minigenes optimized at the 3&#x02032;ss with plasmids expressing SR proteins. Unlike wild-type constructs, minigenes containing 3&#x02032; CAG co-transfected with ASF/SF2, SRp40 and SC35 generated a larger, 1158 bp fragment (<xref ref-type="fig" rid="fig4">Figure 4</xref>, lanes 2&#x02013;4). Sequencing of this RNA product revealed the presence of complete <italic>Alu</italic>Ya5, intron 17 and the 3&#x02032; end of intron 16 in mature transcripts. This isoform was designated Alu-L (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Minigene A with 3&#x02032;CAG generated higher amounts of Alu-L as compared to minigene E containing the same 3&#x02032;CAG mutation (cf. lanes 2 of <xref ref-type="fig" rid="fig4">Figure 4A and B</xref>), suggesting that the deleted segment of intron 16 contains sequences that promote utilization of the predicted 3&#x02032;ss. Cells that were co-transfected with splicing reporters and identical empty vectors lacked Alu-L (lanes 1 in <xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). These results are consistent with promotion of proximal splicing by SR proteins, first observed for ASF/SF2 (<xref ref-type="bibr" rid="b71">71</xref>,<xref ref-type="bibr" rid="b72">72</xref>).</p><p>SR proteins contain one or two N-terminal RRMs and a C-terminal SR domain (<xref ref-type="bibr" rid="b73">73</xref>). To test their requirements for the Alu-L activation, we co-transfected the splicing reporters mutated at the 3&#x02032;CAG with the wild-type and mutated ASF/SF2 plasmids that lacked sequences encoding RRM1, RRM2 and RS domains. In addition, we co-transfected this reporter construct with ASF/SF2 lacking a heptaglycine tract between RRM1 and RRM2 as described (<xref ref-type="bibr" rid="b55">55</xref>). Deletion of RRMs virtually eliminated the Alu-L formation (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, lanes 3&#x02013;4), whereas deletion of the remaining segments was insufficient to prevent the ASF/SF2-induced Alu-L activation, including the RS domain (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, lanes 5 and 6). Similarly, Alu-L could still be induced upon deletion of the RS domain of SRp40 (lanes 7 and 8). Together, these results suggested that interaction of ASF/SF2 RRMs with the pre-mRNA was essential for Alu-L formation and that this process was RS-independent.</p></sec></sec><sec><title>DISCUSSION</title><p>Antisense <italic>Alu</italic>s are amenable to exonization since they contain strong PPTs and several potential 5&#x02032; and 3&#x02032;ss (<xref ref-type="bibr" rid="b32">32</xref>&#x02013;<xref ref-type="bibr" rid="b34">34</xref>). A single, 3&#x02032; <underline>G</underline>AG to 3&#x02032; <underline>C</underline>AG mutation in an <italic>Alu</italic> in the <italic>PGT</italic> gene, which has the 3&#x02032;ss identical to the <italic>ACE Alu</italic>Ya5 (<xref ref-type="table" rid="tbl1">Table 1</xref>), resulted in almost constitutive inclusion in mRNA (<xref ref-type="bibr" rid="b33">33</xref>). In contrast, an identical mutation in <italic>ACE Alu</italic>Ya5 did not result in any inclusion in mature transcripts (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Differential effects of this mutation on <italic>Alu</italic> inclusion could explain a less significant contribution of the younger <italic>Alu</italic>Y subfamily to protein diversity as there are only few examples of <italic>Alu</italic>Y-containing exons (<xref ref-type="bibr" rid="b32">32</xref>).</p><p>Proximal 3&#x02032; AG (positions 280/281, <xref ref-type="table" rid="tbl1">Table 1</xref>) is selected in most exonized <italic>Alu</italic>s that were derived from S subfamilies, whereas the distal AG (positions 276/277) is preferred by exonized <italic>Alu</italic> J sequences (<xref ref-type="bibr" rid="b33">33</xref>). The proximal 3&#x02032;CAG was essential for successful exonization of this element, as we observed no <italic>Alu</italic> inclusion with the 3&#x02032; GAG minigenes carrying strong 5&#x02032;ss at position &#x02212;16 (<xref ref-type="table" rid="tbl2">Table 2</xref>, data not shown). This is consistent with an unproductive use of the proximal 3&#x02032; GAG in most <italic>Alu</italic>-derived exons (<xref ref-type="bibr" rid="b33">33</xref>) and with a general C &#x0223c; T &#x0003e; A &#x0003e; G hierarchy in the 3&#x02032;ss utilization (<xref ref-type="bibr" rid="b63">63</xref>,<xref ref-type="bibr" rid="b64">64</xref>). An apparently inefficient use of the 3&#x02032; CAG (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, lane 2) could be due to a shorter PPT in our constructs (14 uninterrupted Ts) as compared with, on average, 19 &#x000b1; 3 Ts in exonized <italic>Alu</italic>s (<xref ref-type="bibr" rid="b33">33</xref>). The mean size of poly(A) tail of <italic>Alu</italic> S/J and the younger Ya5 was &#x0223c;21 and &#x0223c;26 nt, respectively, whereas the size range of recent, disease-causing <italic>Alu</italic> insertions was between 40 and 97 nt (<xref ref-type="bibr" rid="b74">74</xref>), suggesting that the size of poly(A) tails determines retropositional capability. If in antisense orientation, the 3&#x02032;ss that contain longer tracts may be recognized more efficiently by the spliceosome than <italic>Alu</italic>s with shorter tracts.</p><p>Since the BPS of the new <italic>Alu</italic> exon is located in a flanking intronic sequence, branch site variability may contribute to diverse exonization potential of similar <italic>Alu</italic> elements. This is supported by the observed increase of <italic>Alu</italic> inclusion in minigenes with optimized BPS consensus (lane 4, <xref ref-type="fig" rid="fig2">Figure 2A</xref>) and its elimination in a construct with A<sub>&#x02212;19</sub>&#x0003e;T mutation (lane 5), suggesting that a poor BPS consensus limits exonization of weakly included <italic>Alu</italic>s. Although we did not test if improvement of the 5&#x02032;ss coupled with the optimal BPS would suffice for <italic>Alu</italic> inclusion in constructs containing 3&#x02032;GAG, the enhancement mediated by the <italic>S.cerevisiae</italic> BPS was only minor (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, lane 4).</p><p>Although the predicted 5&#x02032;ss in <italic>ACE Alu</italic> (<xref ref-type="table" rid="tbl2">Table 2</xref>) was not used in the presence of the 3&#x02032; CAG, creation of the 5&#x02032;ss GT consensus resulted in 11% <italic>Alu</italic> inclusion, which was further improved by optimizing 5&#x02032;ss in positions 3 and 5 (<xref ref-type="fig" rid="fig2">Figure 2</xref>, lanes 7, 10, 11 and 13). The GT dinucleotide was essential for <italic>Alu</italic> inclusion, because mutations in these positions did not exonize <italic>Alu</italic>s in constructs lacking the GT consensus (lanes 8 and 9, <xref ref-type="fig" rid="fig2">Figure 2A</xref>). The enhancement of <italic>Alu</italic> inclusion is likely to be mediated by optimized pairing with U1 snRNA, as shown earlier (<xref ref-type="bibr" rid="b34">34</xref>).</p><p>However, the presence of strong traditional splicing signals, including a long PPT, the preferred BPS and optimized 3&#x02032; and 5&#x02032;ss, did not result in complete inclusion of the new <italic>Alu</italic> exon (lane 4 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>). This suggested that auxiliary splicing signals, such as the presence of enhancers or a lack of silencers, or both (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b75">75</xref>), were essential for constitutive <italic>Alu</italic> derepression. Consistent with this assumption, deletion of a predicted enhancer element in <italic>Alu</italic> positions 222&#x02013;228 diminished exonization in the presence of optimized 3&#x02032; and 5&#x02032;ss and mutations in positions conserved in exonized <italic>Alu</italic>s contributed most to <italic>Alu</italic> exclusion (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This segment was predicted by the ESE Finder (<xref ref-type="bibr" rid="b8">8</xref>) as a putative SRp40 binding site with a significant matrix score of 5.2, suggesting that it might be a binding site for this protein, although novel regulatory features in sequences created by deletions could not be excluded (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Although testing of putative ESEs in the exonized <italic>Alu</italic> of the <italic>ADAR2</italic> gene did not identify any splicing auxiliary sequences (<xref ref-type="bibr" rid="b34">34</xref>), this heptamer is present in the <italic>ADAR2 Alu</italic> exon and it will be interesting to examine its activity in other exonized <italic>Alus</italic> and in a heterologous context. The presence of sequences that strongly repress splicing in sense <italic>Alu</italic>s (<xref ref-type="bibr" rid="b55">55</xref>) may contribute to a low exonization potential of these elements. Since antisense <italic>Alu</italic>s also contain sequences that repress splicing (<xref ref-type="bibr" rid="b14">14</xref>), it will be interesting to compare their inhibitory activities in future studies.</p><p>In addition to exonization of <italic>ACE Alu</italic> by optimizing both 3&#x02032; and 5&#x02032;ss, we have shown that this element can be included in mature transcripts in cells over-expressing three SR proteins in the presence of a single point mutation G<sub>282</sub>&#x0003e;C. This effect, which depends critically on the interaction between ASF/SF2 RRMs with the pre-mRNA (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), can be explained by promotion of proximal splicing (<xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b71">71</xref>,<xref ref-type="bibr" rid="b72">72</xref>,<xref ref-type="bibr" rid="b76">76</xref>) or could be attributed to altered mRNA export or translation in co-transfected cells. Future studies should test to what extent, if any, the promotion of proximal splicing depends on the sequences contributed by the I/D <italic>Alu</italic>. Together, these results suggest that &#x0223c;238&#x02009;000 antisense <italic>Alu</italic>s in human introns (<xref ref-type="bibr" rid="b33">33</xref>), which may represent a reservoir of ready-to-use segments expanding protein diversity (<xref ref-type="bibr" rid="b31">31</xref>), have a differential exonization potential and that <italic>trans</italic>-acting factors controlling coupled processes of transcription, splicing and mRNA export play an important role in this process.</p><p>Altered splicing contributes to aberrant expression of genes that may predispose to cardiovascular diseases, including <italic>LDLR</italic>, <italic>LPL</italic>, <italic>LIPA</italic>, <italic>LCAT</italic>, <italic>APOB</italic> and <italic>APOAII</italic> [reviewed in (<xref ref-type="bibr" rid="b77">77</xref>)]. The variability of <italic>ACE</italic> mRNA expression, its sensitivity to external signals and inaccessibility of relevant patient tissues make it difficult to study the importance of <italic>ACE</italic> SNPs in functional assays. Here, we have tested the hypothesis that <italic>ACE</italic> haplotypes and several SNPs flanking the 3&#x02032;ss of intron 16, including IVS16-11C/A, result in differential exon 17 skipping, alter the amounts of natural transcripts and explain putative allelic association with disease. Purine residues around position IVS-11 show a great depletion in the PPTs of several mammals, zebrafish, fugu, ciona and other species (<xref ref-type="bibr" rid="b65">65</xref>), suggesting that this conserved position is important in evolution. As the IVS16-11C&#x0003e;A transversion may weaken the PPT by reducing interaction with the 65 kDa subunit of auxiliary factor of U2 snRNP and other polypyrimidine-binding proteins, carriers of the A allele would be predicted to show increased exon skipping and/or lower expression of natural transcripts. However, the absence of <italic>ACE AluYa5</italic>, which is in tight linkage disequilibrium with the IVS16-11A allele (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), has been associated with a higher ACE activity in plasma and a higher risk of coronary disease (<xref ref-type="bibr" rid="b47">47</xref>,<xref ref-type="bibr" rid="b48">48</xref>,<xref ref-type="bibr" rid="b58">58</xref>). Intron 16 has a strong 5&#x02032;ss (the Shapiro and Senapathy score 89.3) and was spliced out efficiently in our reporter assay (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). A small reduction in the strength of the 3&#x02032;ss scores (71.0 in minigenes A, C and E down to 68.5 in minigenes B, D and F, <xref ref-type="fig" rid="fig1">Figure 1A</xref>) due to IVS16-11A may not lead to recognizable differences in ACE expression. Although neither the exonic SNP nor PPT variants altered splicing (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and minigene assays generally show good reproducibility of the splicing patterns <italic>in vivo</italic>, we cannot formally exclude that the tested SNPs exert differential effect on mRNA expression in relevant tissues or distinct developmental stages. Taken together, our results do not support a role of allele-specific pre-mRNA splicing patterns generated by putative predisposing and protective <italic>ACE</italic> haplotypes in the analyzed gene segment. Future studies should address putative involvement of other <italic>ACE</italic> polymorphisms in mRNA processing, such as the recently implicated SNP rs4362 in a downstream exon (<xref ref-type="bibr" rid="b47">47</xref>).</p></sec></body><back><ack><p>We wish to thank Dr G. Screaton, University of Oxford, and Dr J. C&#x000e1;ceres, Medical Research Council Human Genetics Unit, Edinburgh, for reagents. We thank Dr J. Kralovicova for helpful discussions. This study was supported by the grants from the Wessex Medical Trust (Hope), the University of Southampton School of Medicine, and by the Value in People Award from the Wellcome Trust. Funding to pay the Open Access publication charges for this article was provided by JISC.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="b1"><label>1</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Burge</surname><given-names>C.B.</given-names></name><name><surname>Tuschl</surname><given-names>T.</given-names></name><name><surname>Sharp</surname><given-names>P.A.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Gesteland</surname><given-names>R.F.</given-names></name><name><surname>Cech</surname><given-names>T.R.</given-names></name><name><surname>Atkins</surname><given-names>J.F.</given-names></name></person-group><article-title>Splicing of precursors to mRNAs by the spliceosomes</article-title><source>The RNA World</source><year>1999</year><publisher-loc>Cold Spring Harbor, NY</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><fpage>525</fpage><lpage>560</lpage></citation></ref><ref id="b2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>D.L.</given-names></name></person-group><article-title>Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology</article-title><source>Cell</source><year>2000</year><volume>103</volume><fpage>367</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">11081623</pub-id></citation></ref><ref id="b3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Licklider</surname><given-names>L.J.</given-names></name><name><surname>Gygl</surname><given-names>S.P.</given-names></name><name><surname>Reed</surname><given-names>R.</given-names></name></person-group><article-title>Comprehensive proteomic analysis of the human spliceosome</article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>182</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">12226669</pub-id></citation></ref><ref id="b4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cartegni</surname><given-names>L.</given-names></name><name><surname>Chew</surname><given-names>S.L.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>Listening to silence and understanding nonsense: exonic mutations that affect splicing</article-title><source>Nature Rev. Genet.</source><year>2002</year><volume>3</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">11967553</pub-id></citation></ref><ref id="b5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Stuani</surname><given-names>C.</given-names></name><name><surname>Tzetis</surname><given-names>M.</given-names></name><name><surname>Kanavakis</surname><given-names>E.</given-names></name><name><surname>Efthymiadou</surname><given-names>A.</given-names></name><name><surname>Doudounakis</surname><given-names>S.</given-names></name><name><surname>Casals</surname><given-names>T.</given-names></name><name><surname>Baralle</surname><given-names>F.E.</given-names></name></person-group><article-title>New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12</article-title><source>Hum. Mol. Genet.</source><year>2003</year><volume>12</volume><fpage>1111</fpage><lpage>1120</lpage><pub-id pub-id-type="pmid">12719375</pub-id></citation></ref><ref id="b6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000e1;lovi&#x0010d;ov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Houngninou-Molango</surname><given-names>S.</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>A.</given-names></name><name><surname>Vo&#x00159;echovsk&#x000fd;</surname><given-names>I.</given-names></name></person-group><article-title>Branch sites haplotypes that control alternative splicing</article-title><source>Hum. Mol. Genet.</source><year>2004</year><volume>13</volume><fpage>3189</fpage><lpage>3202</lpage><pub-id pub-id-type="pmid">15496424</pub-id></citation></ref><ref id="b7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fairbrother</surname><given-names>W.G.</given-names></name><name><surname>Yeh</surname><given-names>R.F.</given-names></name><name><surname>Sharp</surname><given-names>P.A.</given-names></name><name><surname>Burge</surname><given-names>C.B.</given-names></name></person-group><article-title>Predictive identification of exonic splicing enhancers in human genes</article-title><source>Science</source><year>2002</year><volume>297</volume><fpage>1007</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">12114529</pub-id></citation></ref><ref id="b8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cartegni</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>M.Q.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>ESEfinder: a web resource to identify exonic splicing enhancers</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>3568</fpage><lpage>3571</lpage><pub-id pub-id-type="pmid">12824367</pub-id></citation></ref><ref id="b9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.H.</given-names></name><name><surname>Chasin</surname><given-names>L.A.</given-names></name></person-group><article-title>Computational definition of sequence motifs governing constitutive exon splicing</article-title><source>Genes Dev.</source><year>2004</year><volume>18</volume><fpage>1241</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">15145827</pub-id></citation></ref><ref id="b10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins</article-title><source>Genes Dev.</source><year>1998</year><volume>12</volume><fpage>1998</fpage><lpage>2012</lpage><pub-id pub-id-type="pmid">9649504</pub-id></citation></ref><ref id="b11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tacke</surname><given-names>R.</given-names></name><name><surname>Manley</surname><given-names>J.L.</given-names></name></person-group><article-title>The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities</article-title><source>EMBO J.</source><year>1995</year><volume>14</volume><fpage>3540</fpage><lpage>3551</lpage><pub-id pub-id-type="pmid">7543047</pub-id></citation></ref><ref id="b12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graveley</surname><given-names>B.R.</given-names></name></person-group><article-title>Sorting out the complexity of SR protein functions</article-title><source>RNA</source><year>2000</year><volume>6</volume><fpage>1197</fpage><lpage>1211</lpage><pub-id pub-id-type="pmid">10999598</pub-id></citation></ref><ref id="b13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>H.</given-names></name><name><surname>Turck</surname><given-names>C.W.</given-names></name><name><surname>Nikolic</surname><given-names>J.M.</given-names></name><name><surname>Black</surname><given-names>D.L.</given-names></name></person-group><article-title>A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer</article-title><source>Genes Dev.</source><year>1997</year><volume>11</volume><fpage>1023</fpage><lpage>1036</lpage><pub-id pub-id-type="pmid">9136930</pub-id></citation></ref><ref id="b14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Chasin</surname><given-names>L.A.</given-names></name></person-group><article-title>Multiple splicing defects in an intronic false exon</article-title><source>Mol. Cell. Biol.</source><year>2000</year><volume>20</volume><fpage>6414</fpage><lpage>6425</lpage><pub-id pub-id-type="pmid">10938119</pub-id></citation></ref><ref id="b15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>N.</given-names></name><name><surname>Kawamoto</surname><given-names>S.</given-names></name></person-group><article-title>An intronic downstream enhancer promotes 3&#x02032; splice site usage of a neural cell-specific exon</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>33641</fpage><lpage>33649</lpage><pub-id pub-id-type="pmid">10931847</pub-id></citation></ref><ref id="b16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deguillien</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>S.C.</given-names></name><name><surname>Moriniere</surname><given-names>M.</given-names></name><name><surname>Dreumont</surname><given-names>N.</given-names></name><name><surname>Benz</surname><given-names>E.J.</given-names><suffix>Jr</suffix></name><name><surname>Baklouti</surname><given-names>F.</given-names></name></person-group><article-title>Multiple <italic>cis</italic> elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation</article-title><source>Blood</source><year>2001</year><volume>98</volume><fpage>3809</fpage><lpage>3816</lpage><pub-id pub-id-type="pmid">11739190</pub-id></citation></ref><ref id="b17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Expert-Bezancon</surname><given-names>A.</given-names></name><name><surname>Le Caer</surname><given-names>J.P.</given-names></name><name><surname>Marie</surname><given-names>J.</given-names></name></person-group><article-title>Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>16614</fpage><lpage>16623</lpage><pub-id pub-id-type="pmid">11867641</pub-id></citation></ref><ref id="b18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hastings</surname><given-names>M.L.</given-names></name><name><surname>Wilson</surname><given-names>C.M.</given-names></name><name><surname>Munroe</surname><given-names>S.H.</given-names></name></person-group><article-title>A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA</article-title><source>RNA</source><year>2001</year><volume>7</volume><fpage>859</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">11421362</pub-id></citation></ref><ref id="b19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCullough</surname><given-names>A.J.</given-names></name><name><surname>Berget</surname><given-names>S.M.</given-names></name></person-group><article-title>G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection</article-title><source>Mol. Cell. Biol.</source><year>1997</year><volume>17</volume><fpage>4562</fpage><lpage>4571</lpage><pub-id pub-id-type="pmid">9234714</pub-id></citation></ref><ref id="b20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>K.J.</given-names></name><name><surname>Ares</surname><given-names>M.</given-names><suffix>Jr</suffix></name></person-group><article-title>Intron self-complementarity enforces exon inclusion in a yeast pre-mRNA</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>12467</fpage><lpage>12472</lpage><pub-id pub-id-type="pmid">9356473</pub-id></citation></ref><ref id="b21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grover</surname><given-names>A.</given-names></name><name><surname>Houlden</surname><given-names>H.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Adamson</surname><given-names>J.</given-names></name><name><surname>Lewis</surname><given-names>J.</given-names></name><name><surname>Prihar</surname><given-names>G.</given-names></name><name><surname>Pickering-Brown</surname><given-names>S.</given-names></name><name><surname>Duff</surname><given-names>K.</given-names></name><name><surname>Hutton</surname><given-names>M.</given-names></name></person-group><article-title>5&#x02032; splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem&#x02013;loop structure that regulates alternative splicing of exon 10</article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>15134</fpage><lpage>15143</lpage><pub-id pub-id-type="pmid">10329720</pub-id></citation></ref><ref id="b22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gabellini</surname><given-names>N.</given-names></name></person-group><article-title>A polymorphic GT repeat from the human cardiac Na<sup>+</sup>/Ca<sup>2+</sup> exchanger intron 2 activates splicing</article-title><source>Eur. J. Biochem.</source><year>2001</year><volume>268</volume><fpage>1076</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">11179974</pub-id></citation></ref><ref id="b23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Buratti</surname><given-names>E.</given-names></name><name><surname>Stuani</surname><given-names>C.</given-names></name><name><surname>Romano</surname><given-names>M.</given-names></name><name><surname>Zuccato</surname><given-names>E.</given-names></name><name><surname>Niksic</surname><given-names>M.</given-names></name><name><surname>Giglio</surname><given-names>L.</given-names></name><name><surname>Faraguna</surname><given-names>D.</given-names></name><name><surname>Baralle</surname><given-names>F.E.</given-names></name></person-group><article-title>Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>21041</fpage><lpage>21047</lpage><pub-id pub-id-type="pmid">10766763</pub-id></citation></ref><ref id="b24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>J.</given-names></name><name><surname>Stangl</surname><given-names>K.</given-names></name><name><surname>Lane</surname><given-names>W.S.</given-names></name><name><surname>Bindereif</surname><given-names>A.</given-names></name></person-group><article-title>HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats</article-title><source>Nature Struct. Biol.</source><year>2003</year><volume>10</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">12447348</pub-id></citation></ref><ref id="b25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Stephan</surname><given-names>W.</given-names></name></person-group><article-title>Compensatory evolution of a precursor messenger RNA secondary structure in the <italic>Drosophila melanogaster Adh</italic> gene</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>11499</fpage><lpage>11504</lpage><pub-id pub-id-type="pmid">12972637</pub-id></citation></ref><ref id="b26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hefferon</surname><given-names>T.W.</given-names></name><name><surname>Groman</surname><given-names>J.D.</given-names></name><name><surname>Yurk</surname><given-names>C.E.</given-names></name><name><surname>Cutting</surname><given-names>G.R.</given-names></name></person-group><article-title>A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>3504</fpage><lpage>3509</lpage><pub-id pub-id-type="pmid">14993601</pub-id></citation></ref><ref id="b27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buratti</surname><given-names>E.</given-names></name><name><surname>Muro</surname><given-names>A.F.</given-names></name><name><surname>Giombi</surname><given-names>M.</given-names></name><name><surname>Gherbassi</surname><given-names>D.</given-names></name><name><surname>Iaconcig</surname><given-names>A.</given-names></name><name><surname>Baralle</surname><given-names>F.E.</given-names></name></person-group><article-title>RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon</article-title><source>Mol. Cell. Biol.</source><year>2004</year><volume>24</volume><fpage>1387</fpage><lpage>1400</lpage><pub-id pub-id-type="pmid">14729981</pub-id></citation></ref><ref id="b28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>G.A.</given-names></name><name><surname>Labuda</surname><given-names>D.</given-names></name><name><surname>Fontaine</surname><given-names>G.</given-names></name><name><surname>Saudubray</surname><given-names>J.M.</given-names></name><name><surname>Bonnefont</surname><given-names>J.P.</given-names></name><name><surname>Lyonnet</surname><given-names>S.</given-names></name><name><surname>Brody</surname><given-names>L.C.</given-names></name><name><surname>Steel</surname><given-names>G.</given-names></name><name><surname>Obie</surname><given-names>C.</given-names></name><name><surname>Valle</surname><given-names>D.</given-names></name></person-group><article-title>Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1991</year><volume>88</volume><fpage>815</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">1992472</pub-id></citation></ref><ref id="b29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knebelmann</surname><given-names>B.</given-names></name><name><surname>Forestier</surname><given-names>L.</given-names></name><name><surname>Drouot</surname><given-names>L.</given-names></name><name><surname>Quinones</surname><given-names>S.</given-names></name><name><surname>Chuet</surname><given-names>C.</given-names></name><name><surname>Benessy</surname><given-names>F.</given-names></name><name><surname>Saus</surname><given-names>J.</given-names></name><name><surname>Antignac</surname><given-names>C.</given-names></name></person-group><article-title>Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome</article-title><source>Hum. Mol. Genet.</source><year>1995</year><volume>4</volume><fpage>675</fpage><lpage>679</lpage><pub-id pub-id-type="pmid">7633417</pub-id></citation></ref><ref id="b30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vervoort</surname><given-names>R.</given-names></name><name><surname>Gitzelmann</surname><given-names>R.</given-names></name><name><surname>Lissens</surname><given-names>W.</given-names></name><name><surname>Liebaers</surname><given-names>I.</given-names></name></person-group><article-title>A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene</article-title><source>Hum. Genet.</source><year>1998</year><volume>103</volume><fpage>686</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">9921904</pub-id></citation></ref><ref id="b31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makalowski</surname><given-names>W.</given-names></name><name><surname>Mitchell</surname><given-names>G.A.</given-names></name><name><surname>Labuda</surname><given-names>D.</given-names></name></person-group><article-title>Alu sequences in the coding regions of mRNA: a source of protein variability</article-title><source>Trends Genet.</source><year>1994</year><volume>10</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">8073532</pub-id></citation></ref><ref id="b32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sorek</surname><given-names>R.</given-names></name><name><surname>Ast</surname><given-names>G.</given-names></name><name><surname>Graur</surname><given-names>D.</given-names></name></person-group><article-title><italic>Alu</italic>-containing exons are alternatively spliced</article-title><source>Genome Res.</source><year>2002</year><volume>12</volume><fpage>1060</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">12097342</pub-id></citation></ref><ref id="b33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lev-Maor</surname><given-names>G.</given-names></name><name><surname>Sorek</surname><given-names>R.</given-names></name><name><surname>Shomron</surname><given-names>N.</given-names></name><name><surname>Ast</surname><given-names>G.</given-names></name></person-group><article-title>The birth of an alternatively spliced exon: 3&#x02032; splice-site selection in <italic>Alu</italic> exons</article-title><source>Science</source><year>2003</year><volume>300</volume><fpage>1288</fpage><lpage>1291</lpage><pub-id pub-id-type="pmid">12764196</pub-id></citation></ref><ref id="b34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sorek</surname><given-names>R.</given-names></name><name><surname>Lev-Maor</surname><given-names>G.</given-names></name><name><surname>Reznik</surname><given-names>M.</given-names></name><name><surname>Dagan</surname><given-names>T.</given-names></name><name><surname>Belinky</surname><given-names>F.</given-names></name><name><surname>Graur</surname><given-names>D.</given-names></name><name><surname>Ast</surname><given-names>G.</given-names></name></person-group><article-title>Minimal conditions for exonization of intronic sequences: 5&#x02032; splice site formation in alu exons</article-title><source>Mol. Cell</source><year>2004</year><volume>14</volume><fpage>221</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">15099521</pub-id></citation></ref><ref id="b35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esther</surname><given-names>C.R.</given-names><suffix>Jr</suffix></name><name><surname>Howard</surname><given-names>T.E.</given-names></name><name><surname>Marino</surname><given-names>E.M.</given-names></name><name><surname>Goddard</surname><given-names>J.M.</given-names></name><name><surname>Capecchi</surname><given-names>M.R.</given-names></name><name><surname>Bernstein</surname><given-names>K.E.</given-names></name></person-group><article-title>Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility</article-title><source>Lab. Invest.</source><year>1996</year><volume>74</volume><fpage>953</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">8642790</pub-id></citation></ref><ref id="b36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esther</surname><given-names>C.R.</given-names></name><name><surname>Marino</surname><given-names>E.M.</given-names></name><name><surname>Howard</surname><given-names>T.E.</given-names></name><name><surname>Machaud</surname><given-names>A.</given-names></name><name><surname>Corvol</surname><given-names>P.</given-names></name><name><surname>Capecchi</surname><given-names>M.R.</given-names></name><name><surname>Bernstein</surname><given-names>K.E.</given-names></name></person-group><article-title>The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice</article-title><source>J. Clin. Invest.</source><year>1997</year><volume>99</volume><fpage>2375</fpage><lpage>2385</lpage><pub-id pub-id-type="pmid">9153279</pub-id></citation></ref><ref id="b37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cambien</surname><given-names>F.</given-names></name><name><surname>Alhenc-Gelas</surname><given-names>F.</given-names></name><name><surname>Herbeth</surname><given-names>B.</given-names></name><name><surname>Andre</surname><given-names>J.L.</given-names></name><name><surname>Rakotovao</surname><given-names>R.</given-names></name><name><surname>Gonzales</surname><given-names>M.F.</given-names></name><name><surname>Allegrini</surname><given-names>J.</given-names></name><name><surname>Bloch</surname><given-names>C.</given-names></name></person-group><article-title>Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study</article-title><source>Am. J. Hum. Genet.</source><year>1988</year><volume>43</volume><fpage>774</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">2847529</pub-id></citation></ref><ref id="b38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>C.A.</given-names></name><name><surname>Abecasis</surname><given-names>G.R.</given-names></name><name><surname>Keavney</surname><given-names>B.</given-names></name><name><surname>Forrester</surname><given-names>T.</given-names></name><name><surname>Ratcliffe</surname><given-names>P.J.</given-names></name><name><surname>Julier</surname><given-names>C.</given-names></name><name><surname>Connell</surname><given-names>J.M.</given-names></name><name><surname>Bennett</surname><given-names>F.</given-names></name><name><surname>McFarlane-Anderson</surname><given-names>N.</given-names></name><name><surname>Lathrop</surname><given-names>G.M.</given-names></name><name><surname>Cardon</surname><given-names>L.R.</given-names></name></person-group><article-title><italic>trans</italic>-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE)</article-title><source>Hum. Mol. Genet.</source><year>2001</year><volume>10</volume><fpage>1077</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">11331618</pub-id></citation></ref><ref id="b39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>C.A.</given-names></name><name><surname>Julier</surname><given-names>C.</given-names></name><name><surname>Forrester</surname><given-names>T.</given-names></name><name><surname>McFarlane-Anderson</surname><given-names>N.</given-names></name><name><surname>Keavney</surname><given-names>B.</given-names></name><name><surname>Lathrop</surname><given-names>G.M.</given-names></name><name><surname>Ratcliffe</surname><given-names>P.J.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name></person-group><article-title>Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci</article-title><source>Am. J. Hum. Genet.</source><year>1995</year><volume>57</volume><fpage>1426</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">8533773</pub-id></citation></ref><ref id="b40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiret</surname><given-names>L.</given-names></name><name><surname>Rigat</surname><given-names>B.</given-names></name><name><surname>Visvikis</surname><given-names>S.</given-names></name><name><surname>Breda</surname><given-names>C.</given-names></name><name><surname>Corvol</surname><given-names>P.</given-names></name><name><surname>Cambien</surname><given-names>F.</given-names></name><name><surname>Soubrier</surname><given-names>F.</given-names></name></person-group><article-title>Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels</article-title><source>Am. J. Hum. Genet.</source><year>1992</year><volume>51</volume><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">1319114</pub-id></citation></ref><ref id="b41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>K.</given-names></name><name><surname>Ishimitsu</surname><given-names>T.</given-names></name><name><surname>Tsuchiya</surname><given-names>N.</given-names></name><name><surname>Horinaka</surname><given-names>S.</given-names></name><name><surname>Matsuoka</surname><given-names>H.</given-names></name></person-group><article-title>Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients</article-title><source>Jpn. Heart J.</source><year>1997</year><volume>38</volume><fpage>799</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">9486933</pub-id></citation></ref><ref id="b42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rigat</surname><given-names>B.</given-names></name><name><surname>Hubert</surname><given-names>C.</given-names></name><name><surname>Alhenc-Gelas</surname><given-names>F.</given-names></name><name><surname>Cambien</surname><given-names>F.</given-names></name><name><surname>Corvol</surname><given-names>P.</given-names></name><name><surname>Soubrier</surname><given-names>F.</given-names></name></person-group><article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title><source>J. Clin. Invest.</source><year>1990</year><volume>86</volume><fpage>1343</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">1976655</pub-id></citation></ref><ref id="b43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soubrier</surname><given-names>F.</given-names></name><name><surname>Martin</surname><given-names>S.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name><name><surname>Visvikis</surname><given-names>S.</given-names></name><name><surname>Tiret</surname><given-names>L.</given-names></name><name><surname>Matsuda</surname><given-names>F.</given-names></name><name><surname>Lathrop</surname><given-names>G.M.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name></person-group><article-title>High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity</article-title><source>Eur. J. Hum. Genet.</source><year>2002</year><volume>10</volume><fpage>553</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">12173033</pub-id></citation></ref><ref id="b44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soubrier</surname><given-names>F.</given-names></name><name><surname>Nadaud</surname><given-names>S.</given-names></name><name><surname>Williams</surname><given-names>T.A.</given-names></name></person-group><article-title>Angiotensin I converting enzyme gene: regulation, polymorphism and implications in cardiovascular diseases</article-title><source>Eur. Heart J.</source><year>1994</year><volume>15</volume><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">7713109</pub-id></citation></ref><ref id="b45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S.</given-names></name><name><surname>Dhillon</surname><given-names>S.</given-names></name><name><surname>Seear</surname><given-names>R.</given-names></name><name><surname>Dunleavey</surname><given-names>L.</given-names></name><name><surname>Day</surname><given-names>L.B.</given-names></name><name><surname>Bannister</surname><given-names>W.</given-names></name><name><surname>Day</surname><given-names>I.N.</given-names></name><name><surname>Simpson</surname><given-names>I.</given-names></name></person-group><article-title>Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis</article-title><source>Heart</source><year>2003</year><volume>89</volume><fpage>1195</fpage><lpage>1199</lpage><pub-id pub-id-type="pmid">12975417</pub-id></citation></ref><ref id="b46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uemura</surname><given-names>K.</given-names></name><name><surname>Nakura</surname><given-names>J.</given-names></name><name><surname>Kohara</surname><given-names>K.</given-names></name><name><surname>Miki</surname><given-names>T.</given-names></name></person-group><article-title>Association of ACE I/D polymorphism with cardiovascular risk factors</article-title><source>Hum. Genet.</source><year>2000</year><volume>107</volume><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">11071385</pub-id></citation></ref><ref id="b47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katzov</surname><given-names>H.</given-names></name><name><surname>Bennet</surname><given-names>A.M.</given-names></name><name><surname>Kehoe</surname><given-names>P.</given-names></name><name><surname>Wiman</surname><given-names>B.</given-names></name><name><surname>Gatz</surname><given-names>M.</given-names></name><name><surname>Blennow</surname><given-names>K.</given-names></name><name><surname>Lenhard</surname><given-names>B.</given-names></name><name><surname>Pedersen</surname><given-names>N.L.</given-names></name><name><surname>de Faire</surname><given-names>U.</given-names></name><name><surname>Prince</surname><given-names>J.A.</given-names></name></person-group><article-title>A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity</article-title><source>Hum. Mol. Genet.</source><year>2004</year><volume>13</volume><fpage>2647</fpage><lpage>2657</lpage><pub-id pub-id-type="pmid">15367486</pub-id></citation></ref><ref id="b48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kehoe</surname><given-names>P.G.</given-names></name><name><surname>Katzov</surname><given-names>H.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Bennet</surname><given-names>A.M.</given-names></name><name><surname>Johansson</surname><given-names>B.</given-names></name><name><surname>Wiman</surname><given-names>B.</given-names></name><name><surname>de Faire</surname><given-names>U.</given-names></name><name><surname>Cairns</surname><given-names>N.J.</given-names></name><name><surname>Wilcock</surname><given-names>G.K.</given-names></name><name><surname>Brookes</surname><given-names>A.J.</given-names></name><etal/></person-group><article-title>Haplotypes extending across ACE are associated with Alzheimer's disease</article-title><source>Hum. Mol. Genet.</source><year>2003</year><volume>12</volume><fpage>859</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">12668609</pub-id></citation></ref><ref id="b49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samani</surname><given-names>N.J.</given-names></name></person-group><article-title>Molecular biology of the renin-angiotensin system: implications for hypertension and beyond</article-title><source>J. Cardiovasc. Pharmacol.</source><year>1991</year><volume>18</volume><issue>Suppl 2</issue><fpage>S1</fpage><lpage>S6</lpage><pub-id pub-id-type="pmid">1725015</pub-id></citation></ref><ref id="b50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sayed-Tabatabaei</surname><given-names>F.A.</given-names></name><name><surname>Houwing-Duistermaat</surname><given-names>J.J.</given-names></name><name><surname>van Duijn</surname><given-names>C.M.</given-names></name><name><surname>Witteman</surname><given-names>J.C.</given-names></name></person-group><article-title>Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis</article-title><source>Stroke</source><year>2003</year><volume>34</volume><fpage>1634</fpage><lpage>1639</lpage><pub-id pub-id-type="pmid">12805498</pub-id></citation></ref><ref id="b51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keavney</surname><given-names>B.</given-names></name><name><surname>McKenzie</surname><given-names>C.</given-names></name><name><surname>Parish</surname><given-names>S.</given-names></name><name><surname>Palmer</surname><given-names>A.</given-names></name><name><surname>Clark</surname><given-names>S.</given-names></name><name><surname>Youngman</surname><given-names>L.</given-names></name><name><surname>Delepine</surname><given-names>M.</given-names></name><name><surname>Lathrop</surname><given-names>M.</given-names></name><name><surname>Peto</surname><given-names>R.</given-names></name><name><surname>Collins</surname><given-names>R.</given-names></name></person-group><article-title>Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International studies of infarct survival (ISIS) collaborators</article-title><source>Lancet</source><year>2000</year><volume>355</volume><fpage>434</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">10841123</pub-id></citation></ref><ref id="b52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keavney</surname><given-names>B.</given-names></name><name><surname>McKenzie</surname><given-names>C.A.</given-names></name><name><surname>Connell</surname><given-names>J.M.</given-names></name><name><surname>Julier</surname><given-names>C.</given-names></name><name><surname>Ratcliffe</surname><given-names>P.J.</given-names></name><name><surname>Sobel</surname><given-names>E.</given-names></name><name><surname>Lathrop</surname><given-names>M.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name></person-group><article-title>Measured haplotype analysis of the angiotensin-I converting enzyme gene</article-title><source>Hum. Mol. Genet.</source><year>1998</year><volume>7</volume><fpage>1745</fpage><lpage>1751</lpage><pub-id pub-id-type="pmid">9736776</pub-id></citation></ref><ref id="b53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name><name><surname>Abecasis</surname><given-names>G.R.</given-names></name><name><surname>Cardon</surname><given-names>L.R.</given-names></name><name><surname>Morton</surname><given-names>N.E.</given-names></name></person-group><article-title>Mapping quantitative effects of oligogenes by allelic association</article-title><source>Ann. Hum. Genet.</source><year>2002</year><volume>66</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">12174212</pub-id></citation></ref><ref id="b54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosatto</surname><given-names>N.</given-names></name><name><surname>Pontremoli</surname><given-names>R.</given-names></name><name><surname>De Ferrari</surname><given-names>G.</given-names></name><name><surname>Ravazzolo</surname><given-names>R.</given-names></name></person-group><article-title>Intron 16 insertion of the angiotensin converting enzyme gene and transcriptional regulation</article-title><source>Nephrol. Dial. Transplant.</source><year>1999</year><volume>14</volume><fpage>868</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">10328461</pub-id></citation></ref><ref id="b55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>H.</given-names></name><name><surname>Vo&#x00159;echovsk&#x000fd;</surname><given-names>I.</given-names></name></person-group><article-title>Identification of splicing silencers and enhancers in sense <italic>Alu</italic>s: a role for pseudo-acceptors in splice site repression</article-title><source>Mol. Cell. Biol.</source><year>2005</year><volume>25</volume><comment>in press</comment></citation></ref><ref id="b56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vo&#x00159;echovsk&#x000fd;</surname><given-names>I.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Dyer</surname><given-names>M.J.</given-names></name><name><surname>Catovsky</surname><given-names>D.</given-names></name><name><surname>Amlot</surname><given-names>P.L.</given-names></name><name><surname>Yaxley</surname><given-names>J.C.</given-names></name><name><surname>Foroni</surname><given-names>L.</given-names></name><name><surname>Hammarstrom</surname><given-names>L.</given-names></name><name><surname>Webster</surname><given-names>A.D.</given-names></name><name><surname>Yuille</surname><given-names>M.A.</given-names></name></person-group><article-title>Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia</article-title><source>Nature Genet.</source><year>1997</year><volume>17</volume><fpage>96</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">9288106</pub-id></citation></ref><ref id="b57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rieder</surname><given-names>M.J.</given-names></name><name><surname>Taylor</surname><given-names>S.L.</given-names></name><name><surname>Clark</surname><given-names>A.G.</given-names></name><name><surname>Nickerson</surname><given-names>D.A.</given-names></name></person-group><article-title>Sequence variation in the human angiotensin converting enzyme</article-title><source>Nature Genet.</source><year>1999</year><volume>22</volume><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">10319862</pub-id></citation></ref><ref id="b58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R.</given-names></name><name><surname>Bouzekri</surname><given-names>N.</given-names></name><name><surname>Martin</surname><given-names>S.</given-names></name><name><surname>Southam</surname><given-names>L.</given-names></name><name><surname>Hugill</surname><given-names>A.</given-names></name><name><surname>Golamaully</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>R.</given-names></name><name><surname>Adeyemo</surname><given-names>A.</given-names></name><name><surname>Soubrier</surname><given-names>F.</given-names></name><name><surname>Ward</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides</article-title><source>Hum. Mol. Genet.</source><year>2002</year><volume>11</volume><fpage>2969</fpage><lpage>2977</lpage><pub-id pub-id-type="pmid">12393808</pub-id></citation></ref><ref id="b59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batzer</surname><given-names>M.A.</given-names></name><name><surname>Kilroy</surname><given-names>G.E.</given-names></name><name><surname>Richard</surname><given-names>P.E.</given-names></name><name><surname>Shaikh</surname><given-names>T.H.</given-names></name><name><surname>Desselle</surname><given-names>T.D.</given-names></name><name><surname>Hoppens</surname><given-names>C.L.</given-names></name><name><surname>Deininger</surname><given-names>P.L.</given-names></name></person-group><article-title>Structure and variability of recently inserted Alu family members</article-title><source>Nucleic Acids Res.</source><year>1990</year><volume>18</volume><fpage>6793</fpage><lpage>6798</lpage><pub-id pub-id-type="pmid">2175877</pub-id></citation></ref><ref id="b60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matera</surname><given-names>A.G.</given-names></name><name><surname>Hellmann</surname><given-names>U.</given-names></name><name><surname>Hintz</surname><given-names>M.F.</given-names></name><name><surname>Schmid</surname><given-names>C.W.</given-names></name></person-group><article-title>Recently transposed Alu repeats result from multiple source genes</article-title><source>Nucleic Acids Res.</source><year>1990</year><volume>18</volume><fpage>6019</fpage><lpage>6023</lpage><pub-id pub-id-type="pmid">2172925</pub-id></citation></ref><ref id="b61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batzer</surname><given-names>M.A.</given-names></name><name><surname>Deininger</surname><given-names>P.L.</given-names></name><name><surname>Hellmann-Blumberg</surname><given-names>U.</given-names></name><name><surname>Jurka</surname><given-names>J.</given-names></name><name><surname>Labuda</surname><given-names>D.</given-names></name><name><surname>Rubin</surname><given-names>C.M.</given-names></name><name><surname>Schmid</surname><given-names>C.W.</given-names></name><name><surname>Zietkiewicz</surname><given-names>E.</given-names></name><name><surname>Zuckerkandl</surname><given-names>E.</given-names></name></person-group><article-title>Standardized nomenclature for Alu repeats</article-title><source>J. Mol. Evol.</source><year>1996</year><volume>42</volume><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8576960</pub-id></citation></ref><ref id="b62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jurka</surname><given-names>J.</given-names></name><name><surname>Kohany</surname><given-names>O.</given-names></name><name><surname>Pavlicek</surname><given-names>A.</given-names></name><name><surname>Kapitonov</surname><given-names>V.V.</given-names></name><name><surname>Jurka</surname><given-names>M.V.</given-names></name></person-group><article-title>Duplication, coclustering, and selection of human Alu retrotransposons</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>1268</fpage><lpage>1272</lpage><pub-id pub-id-type="pmid">14736919</pub-id></citation></ref><ref id="b63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C.W.</given-names></name><name><surname>Chu</surname><given-names>T.T.</given-names></name><name><surname>Nadal-Ginard</surname><given-names>B.</given-names></name></person-group><article-title>Scanning and competition between AGs are involved in 3&#x02032; splice site selection in mammalian introns</article-title><source>Mol. Cell. Biol.</source><year>1993</year><volume>13</volume><fpage>4939</fpage><lpage>4952</lpage><pub-id pub-id-type="pmid">8336728</pub-id></citation></ref><ref id="b64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>R.</given-names></name></person-group><article-title>The organization of 3&#x02032; splice-site sequences in mammalian introns</article-title><source>Genes Dev.</source><year>1989</year><volume>3</volume><fpage>2113</fpage><lpage>2123</lpage><pub-id pub-id-type="pmid">2628164</pub-id></citation></ref><ref id="b65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>G.</given-names></name><name><surname>Hoon</surname><given-names>S.</given-names></name><name><surname>Venkatesh</surname><given-names>B.</given-names></name><name><surname>Burge</surname><given-names>C.B.</given-names></name></person-group><article-title>Variation in sequence and organization of splicing regulatory elements in vertebrate genes</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>15700</fpage><lpage>15705</lpage><pub-id pub-id-type="pmid">15505203</pub-id></citation></ref><ref id="b66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>Y.A.</given-names></name><name><surname>Goldstein</surname><given-names>A.M.</given-names></name><name><surname>Weiner</surname><given-names>A.M.</given-names></name></person-group><article-title>UACUAAC is the preferred branch site for mammalian mRNA splicing</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1989</year><volume>86</volume><fpage>2752</fpage><lpage>2756</lpage><pub-id pub-id-type="pmid">2704744</pub-id></citation></ref><ref id="b67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>K.</given-names></name><name><surname>Reed</surname><given-names>R.</given-names></name></person-group><article-title>An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing</article-title><source>Mol. Cell. Biol.</source><year>2001</year><volume>21</volume><fpage>1509</fpage><lpage>1514</lpage><pub-id pub-id-type="pmid">11238888</pub-id></citation></ref><ref id="b68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname><given-names>X.</given-names></name><name><surname>Sachidanandam</surname><given-names>R.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>Intrinsic differences between authentic and cryptic 5&#x02032; splice sites</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>6321</fpage><lpage>6333</lpage><pub-id pub-id-type="pmid">14576320</pub-id></citation></ref><ref id="b69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname><given-names>X.</given-names></name><name><surname>Sachidanandam</surname><given-names>R.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>Determinants of the inherent strength of human 5&#x02032; splice sites</article-title><source>RNA</source><year>2005</year><volume>11</volume><fpage>683</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">15840817</pub-id></citation></ref><ref id="b70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapitonov</surname><given-names>V.</given-names></name><name><surname>Jurka</surname><given-names>J.</given-names></name></person-group><article-title>The age of Alu subfamilies</article-title><source>J. Mol. Evol.</source><year>1996</year><volume>42</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">8576965</pub-id></citation></ref><ref id="b71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krainer</surname><given-names>A.R.</given-names></name><name><surname>Conway</surname><given-names>G.C.</given-names></name><name><surname>Kozak</surname><given-names>D.</given-names></name></person-group><article-title>The essential pre-mRNA splicing factor SF2 influences 5&#x02032; splice site selection by activating proximal sites</article-title><source>Cell</source><year>1990</year><volume>62</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">2364434</pub-id></citation></ref><ref id="b72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>X.D.</given-names></name><name><surname>Mayeda</surname><given-names>A.</given-names></name><name><surname>Maniatis</surname><given-names>T.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>General splicing factors SF2 and SC35 have equivalent activities <italic>in vitro</italic>, and both affect alternative 5&#x02032; and 3&#x02032; splice site selection</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1992</year><volume>89</volume><fpage>11224</fpage><lpage>11228</lpage><pub-id pub-id-type="pmid">1454802</pub-id></citation></ref><ref id="b73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caceres</surname><given-names>J.F.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains</article-title><source>EMBO J.</source><year>1993</year><volume>12</volume><fpage>4715</fpage><lpage>4726</lpage><pub-id pub-id-type="pmid">8223480</pub-id></citation></ref><ref id="b74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roy-Engel</surname><given-names>A.M.</given-names></name><name><surname>Salem</surname><given-names>A.H.</given-names></name><name><surname>Oyeniran</surname><given-names>O.O.</given-names></name><name><surname>Deininger</surname><given-names>L.</given-names></name><name><surname>Hedges</surname><given-names>D.J.</given-names></name><name><surname>Kilroy</surname><given-names>G.E.</given-names></name><name><surname>Batzer</surname><given-names>M.A.</given-names></name><name><surname>Deininger</surname><given-names>P.L.</given-names></name></person-group><article-title>Active Alu element &#x02018;A-tails&#x02019;: size does matter</article-title><source>Genome Res.</source><year>2002</year><volume>12</volume><fpage>1333</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">12213770</pub-id></citation></ref><ref id="b75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Rolish</surname><given-names>M.E.</given-names></name><name><surname>Yeo</surname><given-names>G.</given-names></name><name><surname>Tung</surname><given-names>V.</given-names></name><name><surname>Mawson</surname><given-names>M.</given-names></name><name><surname>Burge</surname><given-names>C.B.</given-names></name></person-group><article-title>Systematic identification and analysis of exonic splicing silencers</article-title><source>Cell</source><year>2004</year><volume>119</volume><fpage>831</fpage><lpage>845</lpage><pub-id pub-id-type="pmid">15607979</pub-id></citation></ref><ref id="b76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>C&#x000e1;ceres</surname><given-names>J.F.</given-names></name><name><surname>Stamm</surname><given-names>S.</given-names></name><name><surname>Helfman</surname><given-names>D.M.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>Regulation of alternative splicing <italic>in vivo</italic> by overexpression of antagonistic splicing factors</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>1706</fpage><lpage>1709</lpage><pub-id pub-id-type="pmid">8085156</pub-id></citation></ref><ref id="b77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Kodolitsch</surname><given-names>Y.</given-names></name><name><surname>Pyeritz</surname><given-names>R.E.</given-names></name><name><surname>Rogan</surname><given-names>P.K.</given-names></name></person-group><article-title>Splice-site mutations in atherosclerosis candidate genes: relating individual information to phenotype</article-title><source>Circulation</source><year>1999</year><volume>100</volume><fpage>693</fpage><lpage>699</lpage><pub-id pub-id-type="pmid">10449689</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="fig1" position="float"><label>Figure 1</label><caption><p>A lack of a haplotype-specific pre-mRNA splicing pattern of ACE minigenes. (<bold>A</bold>) Construction of <italic>ACE</italic> minigenes. Minigenes A and B were amplified with primers 1 and 2 and a DNA sample with defined <italic>Alu</italic>Ya5 I/D genotype. Minigenes C and D were prepared by deleting a segment of intron 16 with a combination of vector primers and primers 3 and 4. Minigenes E and F were constructed by deleting tandemly arranged sense <italic>Alu</italic> repeats <italic>AluSx</italic> and <italic>AluJb</italic> using primers 4 and 5. Antisense <italic>AluYa5</italic> was present in constructs A, C and E. Primers are shown as black arrows. Exons (E) are represented by boxes, introns by lines. The position and orientation of <italic>Alu</italic> sequences is denoted by grey arrows. Exons, introns and <italic>Alu</italic>s are shown to scale; scale units are kilobases (kb). Exon and intron numbering is consensual as referred to in previous studies (<xref ref-type="bibr" rid="b52">52</xref>,<xref ref-type="bibr" rid="b54">54</xref>). Location of three tested SNPs around the splice acceptor site of intron 16 is shown near the 3&#x02032;ss of intron 16 (the upper panel). Putative susceptibility (minigenes B, D and F) and protective (A, C and E) haplotypes in the indicated SNP are shown as 3 nt above each construct (the lower panel). Lines in the lower panel represent DNA sequences of the <italic>ACE</italic> gene that are present in the indicated minigene, whereas deleted sequences are highlighted with brackets. Alu-E (for Exonized Alu) and Alu-L (for a Long isoform retaining intron 17 and 3&#x02032; end of intron 16) represent RNA products generated by mutated constructs (see <xref ref-type="fig" rid="fig2">Figures 2</xref>&#x02013;<xref ref-type="fig" rid="fig4">4</xref>). Alu-E isoforms spliced to the predicted 5&#x02032;ss (black arrow) and positions &#x02212;16 and +136 relative to the predicted 5&#x02032;ss are shown below the I/D <italic>AluYa5</italic>. (<bold>B</bold>) Haplotype-specific minigenes A&#x02013;F were transfected into 293T cells and their splicing pattern was examined by RT&#x02013;PCR 48 h post-transfection. Exon 17 skipping was not observed after 50 PCR cycles (data not shown). (<bold>C</bold>) A splicing pattern of a truncated minigene individually mutated in the indicated SNPs. We mutated minigene B, which has unabridged intron 16 and lacks <italic>AluYa5</italic> to study a putative effect of these mutations in the natural context and to facilitate mutagenesis.</p></caption><graphic xlink:href="gki707f1"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p><italic>Alu</italic> exonization generated by minigenes mutated in BPS and 3&#x02032; and 5&#x02032;ss. <italic>Alu</italic> inclusion in mRNA was tested following an introduction of a series of mutations at the 3&#x02032;ss, 5&#x02032;ss and the BPS in a minigene transfected into 293T cells. (<bold>A</bold>) Inclusion of <italic>Alu</italic>Ya5 in mature transcripts following mutations in the 5&#x02032;ss, 3&#x02032;ss and the BPS in minigene E, which lacks most of intron 16 to simplify overlap-extension PCR and reduce the proportion of constructs with undesired mutations. AI, <italic>Alu</italic> inclusion levels as a mean (and SD) of triplicate transfections into 293T cells. Inclusion of <italic>Alu</italic>Ya5 in mRNA is indicated by a light grey rectangle on the right side. WT, wild-type BPS CAGUCA<sub>&#x02212;19</sub>C. M, mutation in putative BP A<sub>&#x02212;19</sub>&#x0003e;T; Y, yeast (<italic>S.cerevisiae</italic>) BPS UACUAA<sub>&#x02212;19</sub>C. Adenosine &#x02212;19 was also predicted as a putative BP (BPS score 3.25) through comparison of human and mouse introns (<ext-link ext-link-type="uri" xlink:href="http://ast.bioinfo.tau.ac.il/"/>). (<bold>B</bold>) Nucleotide sequence of the junction (arrow) between upstream exon and exonized <italic>Alu</italic>; (<bold>C</bold>&#x02013;<bold>E</bold>) boundaries (arrow) between the exonized <italic>Alu</italic> and downstream exon generated by optimizing the 5&#x02032;ss in position &#x02212;16 (<bold>C</bold>; see lanes 3 and 4 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>), in the predicted splice sites (<bold>D</bold>; lanes 7, 10, 11 and 13 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>) and in position +136 (<bold>E</bold>).</p></caption><graphic xlink:href="gki707f2"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Identification of a splicing enhancer element in <italic>ACE</italic> intron 16 <italic>Alu</italic>Ya5 Influence of segments 2&#x02013;5 deletions and segment 2 point mutations on <italic>Alu</italic> exonization. (<bold>A</bold>) Exonized <italic>Alu</italic> segment (upper case) with putative ESEs (underlined and numbered 1&#x02013;6). Segments 1, 2 and 6 were predicted by the ESE Finder (<xref ref-type="bibr" rid="b8">8</xref>), segments 1 (C allele only), 3 and 4 were significant ESEs identified through octamer sequences (<xref ref-type="bibr" rid="b9">9</xref>) and segment 5 was predicted by the RESCUE-ESE (<xref ref-type="bibr" rid="b7">7</xref>). Intronic sequence is in lower case. To facilitate mutagenesis, segments 2 through 5 were individually deleted in minigene E&#x02032;. This minigene contained intron 16 truncation (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and four point mutations optimizing the splice sites (shown below the nucleotide sequence in bold). A segment 2, which was mutated individually in each position, is in the middle of the sequence in bold. (<bold>B</bold>) <italic>Alu</italic> inclusion levels following deletions of segments 2&#x02013;5 and point mutations in segment 2. Transfection of all splicing reporters was into 293T cells. AI, <italic>Alu</italic> inclusion. (<bold>C</bold>) <italic>Alu</italic> inclusion levels in double mutants of minigene E. (<bold>D</bold>) Consensus sequence of segment 2 heptamer in alternatively spliced exons containing right arms of antisense <italic>Alu</italic>s as identified previously (<xref ref-type="bibr" rid="b34">34</xref>). Representation of each heptamer position (numbered above) and flanking sequences was visualized using a pictogram utility available at <ext-link ext-link-type="uri" xlink:href="http://genes.mit.edu/pictogram.html"/>.</p></caption><graphic xlink:href="gki707f3"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>SR-mediated activation of the 3&#x02032;ss of <italic>ACE Alu</italic>Ya5. Minigenes A and E were co-transfected with plasmids expressing a subset of SR proteins. (<bold>A</bold>) Inclusion of <italic>ACE</italic> IVS16 <italic>Alu</italic>Ya5 in mature transcripts in 293T cells transfected with 0.5 &#x003bc;g of minigene A containing 3&#x02032; CAG and 1 &#x003bc;g of plasmids expressing the indicated proteins. (<bold>B</bold>) RRMs are critical ASF/SF2 domains for the Alu-L formation. ASF-dRRM1, ASF-dRRM2, ASF-dRS and ASF-dGly denote ASF/SF2 lacking RRM1, RRM2, the RS domain and a heptaglycine stretch, respectively. WT, wild-type. Inclusion levels are mean values (SD) of two independent transfection experiments.</p></caption><graphic xlink:href="gki707f4"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Sequence alignment of the 3&#x02032; splice sites of <italic>ACE</italic> I/D <italic>Alu</italic>Ya5 and <italic>Alu</italic>J/S consensus sequences</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" colspan="1" rowspan="1"><graphic xlink:href="gki707t1"/></td></tr></tbody></table><table-wrap-foot><fn id="tf1-1"><p><sup>a</sup>Position is relative to the proximal 3&#x02032; AG. Sequence variations are in bold. Minigene mutation is indicated in italics. Position in the Alu consensus sequence (<xref ref-type="bibr" rid="b33">33</xref>) is indicated by a subscript. Proximal (Alu position 280 and 281) and distal (276 and 277) AGs are shaded. <italic>PGT Alu</italic> was significantly exonized following a single G<sub>282</sub>&#x0003e;C mutation (<xref ref-type="bibr" rid="b33">33</xref>).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Minigene mutations at the 5&#x02032; splice sites</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" colspan="1" rowspan="1"><graphic xlink:href="gki707t2"/></td></tr></tbody></table><table-wrap-foot><fn id="tf2-1"><p><sup>a</sup>Position is relative to the predicted 5&#x02032;ss. Position in the consensus <italic>Alu</italic> sequence (<xref ref-type="bibr" rid="b33">33</xref>) is subscripted.</p></fn><fn id="tf2-2"><p><sup>b</sup>Position +220 is downstream of <italic>Alu</italic> I/D. The 5&#x02032; GT is shaded. P, clones mutated in predicted 5&#x02032;ss.</p></fn></table-wrap-foot></table-wrap></sec></back></article> 